aminolevulinic acid has been researched along with Fatty Liver in 2 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatty liver models of methionine- and choline-deficient high-fat mice were subjected to I/R injury with or without 5-aminolevulinic acid (5-ALA)/sodium ferrous citrate (SFC) treatment." | 7.83 | 5-Aminolevulinic acid combined with ferrous iron ameliorate ischemia-reperfusion injury in the mouse fatty liver model. ( Fujino, M; Ito, H; Kakuta, Y; Li, S; Li, XK; Liu, C; Nakajima, M; Nonomura, N; Sugiyama, T; Takahara, S; Takahara, T; Takahashi, K; Tanaka, T; Tsukada, K, 2016) |
| "Fatty liver models of methionine- and choline-deficient high-fat mice were subjected to I/R injury with or without 5-aminolevulinic acid (5-ALA)/sodium ferrous citrate (SFC) treatment." | 3.83 | 5-Aminolevulinic acid combined with ferrous iron ameliorate ischemia-reperfusion injury in the mouse fatty liver model. ( Fujino, M; Ito, H; Kakuta, Y; Li, S; Li, XK; Liu, C; Nakajima, M; Nonomura, N; Sugiyama, T; Takahara, S; Takahara, T; Takahashi, K; Tanaka, T; Tsukada, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, H | 1 |
| Zhang, M | 1 |
| Ma, Y | 1 |
| Lu, J | 1 |
| Pan, J | 1 |
| Pan, P | 1 |
| Chen, H | 1 |
| Jia, W | 1 |
| Li, S | 1 |
| Takahara, T | 1 |
| Li, XK | 1 |
| Fujino, M | 1 |
| Sugiyama, T | 1 |
| Tsukada, K | 1 |
| Liu, C | 1 |
| Kakuta, Y | 1 |
| Nonomura, N | 1 |
| Ito, H | 1 |
| Takahashi, K | 1 |
| Nakajima, M | 1 |
| Tanaka, T | 1 |
| Takahara, S | 1 |
2 other studies available for aminolevulinic acid and Fatty Liver
| Article | Year |
|---|---|
5-ALA ameliorates hepatic steatosis through AMPK signaling pathway.
Topics: Adipose Tissue; Aminolevulinic Acid; AMP-Activated Protein Kinases; Animals; Blood Glucose; Body Wei | 2017 |
5-Aminolevulinic acid combined with ferrous iron ameliorate ischemia-reperfusion injury in the mouse fatty liver model.
Topics: Aminolevulinic Acid; Animals; Cytokines; Drug Combinations; Fatty Liver; Ferrous Compounds; Kupffer | 2016 |